VISTAGEN THERAPEUTICS, INC. Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit
VISTAGEN THERAPEUTICS, INC. (VTGN) had Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit of $11.94 per share as of 2022-09-12, per its 10-K filed 2023-06-28.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit · last filed 2023-06-28
- 2022-09-12: Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit $11.94; Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit as first filed $0.40.
| Period end | Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit | Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit as first filed |
|---|---|---|
| 2022-09-12 | $11.94 10-K · filed 2023-06-28 | $0.40 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |